-
Disease Progression Patterns of Brain Morphology in Schizophrenia: More Progressed Stages in Treatment Resistance Schizophr. Bull. (IF 6.6) Pub Date : 2023-11-26 Daichi Sone, Alexandra Young, Shunichiro Shinagawa, Sakiko Tsugawa, Yusuke Iwata, Ryosuke Tarumi, Kamiyu Ogyu, Shiori Honda, Ryo Ochi, Karin Matsushita, Fumihiko Ueno, Nobuaki Hondo, Akihiro Koreki, Edgardo Torres-Carmona, Wanna Mar, Nathan Chan, Teruki Koizumi, Hideo Kato, Keisuke Kusudo, Vincenzo de Luca, Philip Gerretsen, Gary Remington, Mitsumoto Onaya, Yoshihiro Noda, Hiroyuki Uchida, Masaru Mimura
Background and Hypothesis Given the heterogeneity and possible disease progression in schizophrenia, identifying the neurobiological subtypes and progression patterns in each patient may lead to novel biomarkers. Here, we adopted data-driven machine-learning techniques to identify the progression patterns of brain morphological changes in schizophrenia and investigate the association with treatment
-
Consent for Research Involving Spanish- and English-Speaking Latinx Adults With Schizophrenia Schizophr. Bull. (IF 6.6) Pub Date : 2023-11-14 Concepción Barrio, Dahlia Fuentes, Lize Tibiriçá, Mercedes Hernandez, Paula Helu-Brown, Shahrokh Golshan, Barton W Palmer
Background Latinxs are vastly underrepresented in mental health research; one of many contributing factors may be complexities in the research consent process, including language preferences. We examined determinants of comprehension of research consent procedures and tested the effects of a preconsent research schema condition among 180 adults with schizophrenia (60 Latinx-English and 60 Latinx-Spanish
-
Clinical Assessment Interview for Negative Symptoms (CAINS): A Systematic Review of Measurement Properties Schizophr. Bull. (IF 6.6) Pub Date : 2023-11-12 Sophia Wehr, Lucia Weigel, John Davis, Silvana Galderisi, Armida Mucci, Stefan Leucht
Background and Hypothesis Negative symptoms are very important for the overall loss of functioning observed in patients with schizophrenia. There is a need for valid tools to assess these symptoms. Study Design We used the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) systematic review guideline to evaluate the quality of the clinical assessment interview for
-
Corollary Discharge Dysfunction as a Possible Substrate of Anomalous Self-experiences in Schizophrenia Schizophr. Bull. (IF 6.6) Pub Date : 2023-11-11 Rosa M Beño-Ruiz-de-la-Sierra, Antonio Arjona-Valladares, Marta Hernández-García, Inés Fernández-Linsenbarth, Álvaro Díez, Sabela Fondevila Estevez, Carolina Castaño, Francisco Muñoz, Javier Sanz-Fuentenebro, Alejandro Roig-Herrero, Vicente Molina
Background and Hypothesis Corollary discharge mechanism suppresses the conscious auditory sensory perception of self-generated speech and attenuates electrophysiological markers such as the auditory N1 Event-Related Potential (ERP) during Electroencephalographic (EEG) recordings. This phenomenon contributes to self-identification and seems to be altered in people with schizophrenia. Therefore, its
-
Targeted Treatment of Schizophrenia Symptoms as They Manifest, or Continuous Treatment to Reduce the Risk of Psychosis Recurrence Schizophr. Bull. (IF 6.6) Pub Date : 2023-11-06 Michael Davidson, William T Carpenter
Current pharmacological treatment of schizophrenia employs drugs that interfere with dopamine neurotransmission, aiming to suppress acute exacerbation of psychosis and maintenance treatment to reduce the risk of psychosis recurrence. According to this treatment scheme, available psychotropic drugs intended to treat negative symptoms, cognitive impairment, or anxiety are administered as add-ons to treatment
-
The Effect of Accelerated Continuous Theta Burst Stimulation on Weight Loss in Overweight Individuals With Schizophrenia: A Double-Blind, Randomized, Sham-Controlled Clinical Trial Schizophr. Bull. (IF 6.6) Pub Date : 2023-11-03 Dongyu Kang, Yi Zhang, Guowei Wu, Chuhan Song, Xinjie Peng, Yujun Long, Guo Yu, Hui Tang, Yawei Gui, Quan Wang, Tifei Yuan, Renrong Wu
Background and Hypothesis Obesity is a common comorbidity in individuals with schizophrenia and is associated with poor clinical outcomes. At present, there are limited effective approaches for addressing this issue. We conducted a double-blind, randomized, sham-controlled clinical trial to investigate the efficacy of noninvasive magnetic stimulation techniques in reducing obesity in individuals with
-
Up-regulation of the Trace Amine Receptor, TAAR-1, in the Prefrontal Cortex of Individuals Affected by Schizophrenia Schizophr. Bull. (IF 6.6) Pub Date : 2023-10-28 Tiziana Imbriglio, Marika Alborghetti, Valeria Bruno, Giuseppe Battaglia, Ferdinando Nicoletti, Milena Cannella
Background and Hypothesis Type-1 trace amine-associated receptors (TAAR1) modulate dopaminergic and glutamatergic neurotransmission and are targeted by novel antipsychotic drugs. We hypothesized that schizophrenia (SCZ) causes adaptive changes in TAAR1 expression in the prefrontal cortex. Study Design We measured TAAR1 mRNA and protein levels by quantitative PCR and immunoblotting in post-mortem prefrontal
-
Combinations and Temporal Associations Among Precursor Symptoms Before a First Episode of Psychosis Schizophr. Bull. (IF 6.6) Pub Date : 2023-10-20 Vincent Paquin, Ashok K Malla, Srividya N Iyer, Martin Lepage, Ridha Joober, Jai L Shah
Background and Hypothesis Symptoms that precede a first episode of psychosis (FEP) can ideally be targeted by early intervention services with the aim of preventing or delaying psychosis onset. However, these precursor symptoms emerge in combinations and sequences that do not rest fully within traditional diagnostic categories. To advance our understanding of illness trajectories preceding FEP, we
-
Violent Offending in Males With or Without Schizophrenia: A Role for Social Cognition? Schizophr. Bull. (IF 6.6) Pub Date : 2023-10-20 Anja Vaskinn, Jaroslav Rokicki, Christina Bell, Natalia Tesli, Nina Bang, Gabriela Hjell, Thomas Fischer-Vieler, Unn K Haukvik, Christine Friestad
Background and Hypothesis Reduced social cognition has been reported in individuals who have committed interpersonal violence. It is unclear if individuals with schizophrenia and a history of violence have larger impairments than violent individuals without psychosis and non-violent individuals with schizophrenia. We examined social cognition in two groups with violent offenses, comparing their performance
-
Exploring the Relationship Between Suicidality and Persistent Negative Symptoms Following a First Episode of Psychosis Schizophr. Bull. (IF 6.6) Pub Date : 2023-10-17 Joseph Ghanem, Massimiliano Orri, Laura Moro, Katie M Lavigne, Delphine Raucher-Chéné, Ashok Malla, Ridha Joober, Martin Lepage
Background and Hypothesis Suicide is a leading cause of death in first-episode psychosis (FEP), with an elevated risk during the first year following illness onset. The association between negative symptoms and suicidality remains contentious. Some studies suggest that negative symptoms may be associated with lower suicidality, while others fail to find an association between the two. No previous studies
-
Multimodal Neuroimaging Summary Scores as Neurobiological Markers of Psychosis Schizophr. Bull. (IF 6.6) Pub Date : 2023-10-16 Amanda L Rodrigue, Rebecca A Hayes, Emma Waite, Mary Corcoran, David C Glahn, Maria Jalbrzikowski
Background and Hypothesis Structural brain alterations are well-established features of schizophrenia but they do not effectively predict disease/disease risk. Similar to polygenic risk scores in genetics, we integrated multifactorial aspects of brain structure into a summary “Neuroscore” and examined its potential as a marker of disease. Study Design We extracted measures from T1-weighted scans and
-
Evidence for Reduced Sensory Precision and Increased Reliance on Priors in Hallucination-Prone Individuals in a General Population Sample Schizophr. Bull. (IF 6.6) Pub Date : 2023-10-13 David Benrimoh, Victoria L Fisher, Rashina Seabury, Ely Sibarium, Catalina Mourgues, Doris Chen, Albert Powers
Background There is increasing evidence that people with hallucinations overweight perceptual beliefs relative to incoming sensory evidence. Past work demonstrating prior overweighting has used simple, nonlinguistic stimuli. However, auditory hallucinations in psychosis are often complex and linguistic. There may be an interaction between the type of auditory information being processed and its perceived
-
Self-concept and Narrative Identity in Youth at Clinical High Risk for Psychosis Schizophr. Bull. (IF 6.6) Pub Date : 2023-10-11 Henry R Cowan, Dan P McAdams, Leah Ouellet, Courtney M Jones, Vijay A Mittal
Background and Hypothesis Disturbances of the narrative self and personal identity accompany the onset of psychotic disorders in late adolescence and early adulthood (a formative developmental stage for self-concept and personal narratives). However, these issues have primarily been studied retrospectively after illness onset, limiting any inferences about their developmental course. Study Design Youth
-
Understanding the Causal Pathway of Social Determinants of Psychosis: The Role of Social Functioning, Relevance of Animal Models, and Implications for Treatment Schizophr. Bull. (IF 6.6) Pub Date : 2023-09-06 Amy M Jimenez, Michael F Green
There is mounting evidence that the social determinants of psychosis operate via a long and circuitous route. Here, we comment on the striking findings from a recent study by Ku et al., that area-level social environmental factors yield social disability and increased risk for schizophrenia through intervening variables and over a long time course. We discuss the relevance of animal models of social
-
A Child–Parent Dyad Study on Adolescent Paranoia and the Influence of Adverse Life Events, Bullying, Parenting Stress, and Family Support Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-25 Jessica L Kingston, Lyn Ellett, Elizabeth C Thompson, Brandon A Gaudiano, Katarina Krkovic
Background Paranoid beliefs commonly occur in the general adolescent population. Exposure to adverse life events (ALEs) and/or bullying are important environmental risk factors. The extent to which others, especially parents, are available to help a young person cope with stressful situations may offset this risk. Study Design A cross-sectional adolescent-parent dyad design (n = 142 pairs) was used
-
Hallucination-Proneness is Associated With a Decrease in Robust Averaging of Perceptual Evidence Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-25 Emmett M Larsen, Jingwen Jin, Xian Zhang, Kayla R Donaldson, Megan Liew, Guillermo Horga, Christian Luhmann, Aprajita Mohanty
Background and Hypothesis Hallucinations are characterized by disturbances in perceptual decision-making about environmental stimuli. When integrating across multiple stimuli to form a perceptual decision, typical observers engage in “robust averaging” by down-weighting extreme perceptual evidence, akin to a statistician excluding outlying data. Furthermore, observers adapt to contexts with more unreliable
-
Antipsychotic Medication and Risk of Metabolic Disorders in People With Schizophrenia: A Longitudinal Study Using the UK Clinical Practice Research Datalink Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-25 Emily Eyles, Ruta Margelyte, Hannah B Edwards, Paul A Moran, David S Kessler, Simon J C Davies, Blanca Bolea-Alamañac, Maria Theresa Redaniel, Sarah A Sullivan
Background and Hypothesis Antipsychotics are first-line drug treatments for schizophrenia. When antipsychotic monotherapy is ineffective, combining two antipsychotic drugs is common although treatment guidelines warn of possible increases in side effects. Risks of metabolic side effects with antipsychotic polypharmacy have not been fully investigated. This study examined associations between antipsychotic
-
Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia Spectrum Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-22 Julia Schulz, Felix Brandl, Michel J Grothe, Matthias Kirschner, Stefan Kaiser, André Schmidt, Stefan Borgwardt, Josef Priller, Christian Sorg, Mihai Avram
Background and Hypothesis The cholinergic system is altered in schizophrenia. Particularly, patients’ volumes of basal-forebrain cholinergic nuclei (BFCN) are lower and correlated with attentional deficits. It is unclear, however, if and how BFCN changes and their link to cognitive symptoms extend across the schizophrenia spectrum, including individuals with at-risk mental state for psychosis (ARMS)
-
Altered Temporal Dynamics of Resting-State Functional Magnetic Resonance Imaging in Adolescent-Onset First-Episode Psychosis Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-22 Mireia Masias Bruns, Juan Pablo Ramirez-Mahaluf, Isabel Valli, María Ortuño, Daniel Ilzarbe, Elena de la Serna, Olga Puig Navarro, Nicolas A Crossley, Miguel Ángel González Ballester, Inmaculada Baeza, Gemma Piella, Josefina Castro-Fornieles, Gisela Sugranyes
Background Dynamic functional connectivity (dFC) alterations have been reported in patients with adult-onset and chronic psychosis. We sought to examine whether such abnormalities were also observed in patients with first episode, adolescent-onset psychosis (AOP), in order to rule out potential effects of chronicity and protracted antipsychotic treatment exposure. AOP has been suggested to have less
-
Familial Risk for Schizophrenia vs Bipolar Disorder and Task-Based Neural Activation: A functional Magnetic Resonance Imaging Meta-Analysis Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-22 Petra E Rupert, Michael Pogue-Geile
Background and Hypothesis Individuals at familial risk for developing schizophrenia (FRSZ) or bipolar disorder (FRBD) have shared and unique genetic risks. Few studies have compared neural activation between these two groups. Therefore, the present meta-analysis investigated functional brain similarities and differences between FRSZ and FRBD individuals. Study Design A systematic literature review
-
Methodological Characteristics and Feasibility of Ecological Momentary Assessment Studies in Psychosis: a Systematic Review and Meta-Analysis Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-22 Imogen H Bell, Emily Eisner, Stephanie Allan, Sharla Cartner, John Torous, Sandra Bucci, Neil Thomas
Background Ecological momentary assessment (EMA) involves completing multiple surveys over time in daily life, capturing in-the-moment experiences in real-world contexts. EMA use in psychosis studies has surged over several decades. To critically examine EMA use in psychosis research and assist future researchers in designing new EMA studies, this systematic review aimed to summarize the methodological
-
Medical and Psychiatric Care Preceding the First Psychotic Disorder Diagnosis Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-22 Nicole M Benson, Zhiyou Yang, Vicki Fung, Sharon-Lise Normand, Matcheri S Keshavan, Dost Öngür, John Hsu
Background Individuals with psychotic symptoms experience substantial morbidity and have shortened life expectancies; early treatment may mitigate the worst effects. Understanding care preceding a first psychotic disorder diagnosis is critical to inform early detection and intervention. Study Design In this observational cohort study using comprehensive information from the Massachusetts All-Payer
-
Associating Multimodal Neuroimaging Abnormalities With the Transcriptome and Neurotransmitter Signatures in Schizophrenia Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-22 Yuling Luo, Debo Dong, Huan Huang, Jingyu Zhou, Xiaojun Zuo, Jian Hu, Hui He, Sisi Jiang, Mingjun Duan, Dezhong Yao, Cheng Luo
Background and Hypothesis Schizophrenia is a multidimensional disease. This study proposes a new research framework that combines multimodal meta-analysis and genetic/molecular architecture to solve the consistency in neuroimaging biomarkers of schizophrenia and whether these link to molecular genetics. Study Design We systematically searched Web of Science, PubMed, and BrainMap for the amplitude of
-
Longitudinal MicroRNA Signature of Conversion to Psychosis Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-22 Anton Iftimovici, Qin He, Chuan Jiao, Edouard Duchesnay, Marie-Odile Krebs, Oussama Kebir, Boris Chaumette
Background and Hypothesis The emergence of psychosis in ultra-high-risk subjects (UHR) is influenced by gene-environment interactions that rely on epigenetic mechanisms such as microRNAs. However, whether they can be relevant pathophysiological biomarkers of psychosis’ onset remains unknown. Study Design We present a longitudinal study of microRNA expression, measured in plasma by high-throughput sequencing
-
Serious Mental Illness, Glycemic Control, and Neighborhood Factors within an Urban Diabetes Cohort Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-19 Esti Iturralde, Anna D Rubinsky, Kim H Nguyen, Chelsie Anderson, Courtney R Lyles, Christina Mangurian
Background and Hypothesis Serious mental illness (SMI) may compromise diabetes self-management. This study assessed the association between SMI and glycemic control, and explored sociodemographic predictors and geographic clustering of this outcome among patients with and without SMI. Study Design We used electronic health record data for adult primary care patients with diabetes from 2 San Francisco
-
Effects of Exercise on Structural and Functional Brain Patterns in Schizophrenia—Data From a Multicenter Randomized-Controlled Study Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-19 Lukas Roell, Daniel Keeser, Boris Papazov, Moritz Lembeck, Irina Papazova, David Greska, Susanne Muenz, Thomas Schneider-Axmann, Eliska B Sykorova, Christina E Thieme, Bob O Vogel, Sebastian Mohnke, Charlotte Huppertz, Astrid Roeh, Katriona Keller-Varady, Berend Malchow, Sophia Stoecklein, Birgit Ertl-Wagner, Karsten Henkel, Bernd Wolfarth, Wladimir Tantchik, Henrik Walter, Dusan Hirjak, Andrea Schmitt
Background and Hypothesis Aerobic exercise interventions in people with schizophrenia have been demonstrated to improve clinical outcomes, but findings regarding the underlying neural mechanisms are limited and mainly focus on the hippocampal formation. Therefore, we conducted a global exploratory analysis of structural and functional neural adaptations after exercise and explored their clinical implications
-
Prefrontal and Hippocampal Parvalbumin Interneurons in Animal Models for Schizophrenia: A Systematic Review and Meta-analysis Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-16 Thamyris Santos-Silva, Débora dos Santos Fabris, Cilene Lino de Oliveira, Francisco S Guimarães, Felipe V Gomes
Background Consistent with postmortem findings in patients, most animal models for schizophrenia (SCZ) present abnormal levels of parvalbumin (PV), a marker of fast-spiking GABAergic interneurons, in the prefrontal cortex (PFC) and hippocampus (HIP). However, there are discrepancies in the literature. PV reductions lead to a functional loss of PV interneurons, which is proposed to underly SCZ symptoms
-
Immune-Inflammatory Response And Compensatory Immune-Regulatory Reflex Systems And White Matter Integrity in Schizophrenia Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-04 Mengzhuang Gou, Wenjin Chen, Yanli Li, Song Chen, Wei Feng, Shujuan Pan, Xingguang Luo, Shuping Tan, Baopeng Tian, Wei Li, Jinghui Tong, Yanfang Zhou, Hongna Li, Ting Yu, Zhiren Wang, Ping Zhang, Junchao Huang, Peter Kochunov, Li Tian, Chiang-Shan R Li, L Elliot Hong, Yunlong Tan
Background and Hypothesis Low-grade neural and peripheral inflammation are among the proposed pathophysiological mechanisms of schizophrenia. White matter impairment is one of the more consistent findings in schizophrenia but the underlying mechanism remains obscure. Many cerebral white matter components are sensitive to neuroinflammatory conditions that can result in demyelination, altered oligodendrocyte
-
The Relevance of Animal Models of Social Isolation and Social Motivation for Understanding Schizophrenia: Review and Future Directions Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-01 Susan B Powell, Neal R Swerdlow
Background and Hypotheses Social dysfunction in schizophrenia includes symptoms of withdrawal and deficits in social skills, social cognition, and social motivation. Based on the course of illness, with social withdrawal occurring prior to psychosis onset, it is likely that the severity of social withdrawal/isolation contributes to schizophrenia neuropathology. Study Design We review the current literature
-
Predictors of Mortality Following a Schizophrenia Spectrum Diagnosis: Evidence From the 20-Year Follow-up of the OPUS Randomized Controlled Trial Schizophr. Bull. (IF 6.6) Pub Date : 2023-08-01 Marie Stefanie Kejser Starzer, Helene Gjervig Hansen, Carsten Hjorthøj, Helene Speyer, Nikolai Albert, Merete Nordentoft
Background and Hypothesis The life expectancy of patients diagnosed with schizophrenia is 10–12 years lower than in the general population and the mortality gap seems to be worsening. Many of these deaths might be avoidable. We aimed to determine mortality rates and causes of death after a first-episode psychosis, and to examine if clinical characteristics at baseline or during illness could predict
-
Resolving the Delusion Paradox Schizophr. Bull. (IF 6.6) Pub Date : 2023-07-21 Predrag Petrovic, Philipp Sterzer
Background and Hypothesis The neurocomputational framework of predictive processing (PP) provides a promising approach to explaining delusions, a key symptom of psychotic disorders. According to PP, the brain makes inferences about the world by weighing prior beliefs against the available sensory data. Mismatches between prior beliefs and sensory data result in prediction errors that may update the
-
Temporal Interactions Between Social Motivation and Behavior In Daily Life Among Individuals at Clinical High-Risk for Psychosis Schizophr. Bull. (IF 6.6) Pub Date : 2023-07-20 Gregory P Strauss, Ian M Raugh, Lauren Luther, Elaine F Walker, Vijay A Mittal
Background and Hypotheses Poor social functioning is common among individuals at clinical high-risk (CHR) for psychosis and is associated with greater likelihood of conversion. Unfortunately, processes contributing to social impairment are unclear, making social functioning difficult to improve via treatment. The current study examined whether abnormalities in social functioning result from aberrant
-
Epidemiological and Genetic Analyses of Schizophrenia and Breast Cancer Schizophr. Bull. (IF 6.6) Pub Date : 2023-07-19 Mingshuang Tang, Xueyao Wu, Wenqiang Zhang, Huijie Cui, Li Zhang, Peijing Yan, Chao Yang, Yutong Wang, Lin Chen, Chenghan Xiao, Yunjie Liu, Yanqiu Zou, Chunxia Yang, Ling Zhang, Yuqin Yao, Zhenmi Liu, Jiayuan Li, Xia Jiang, Ben Zhang
Background and Hypothesis While the phenotypic association between schizophrenia and breast cancer has been observed, the underlying intrinsic link is not adequately understood. We aim to conduct a comprehensive interrogation on both phenotypic and genetic relationships between schizophrenia and breast cancer. Study Design We first used data from UK Biobank to evaluate a phenotypic association and
-
Retinal Neurodegeneration as a Potential Biomarker of Accelerated Aging in Schizophrenia Spectrum Disorders Schizophr. Bull. (IF 6.6) Pub Date : 2023-07-17 Brittany A Blose, Adriann Lai, Christen Crosta, Judy L Thompson, Steven M Silverstein
Background and Hypotheses Several biological markers are believed to reflect accelerated aging in schizophrenia spectrum disorders; however, retinal neural changes have not yet been explored as potential CNS biomarkers of accelerated aging in this population. The aim of this study was to determine whether retinal neural layer thinning is more strongly related to age in schizophrenia and schizoaffective
-
The Nature of the Familial Risk for Psychosis in Bipolar Disorder Schizophr. Bull. (IF 6.6) Pub Date : 2023-07-13 Kenneth S Kendler, Linda Abrahamsson, Jan Sundquist, Kristina Sundquist
Background and Hypothesis To clarify whether the familial liability to psychosis associated with bipolar disorder (BD) is nonspecific or has a greater effect on risk for psychosis in cases with prominent mood symptoms and/or a remitting course. Study Design We examined, in 984 809 offspring raised in intact families in Sweden, born 1980–1996 and followed-up through 2018, by multivariable Cox proportional
-
Social Withdrawal, Loneliness, and Health in Schizophrenia: Psychological and Neural Mechanisms Schizophr. Bull. (IF 6.6) Pub Date : 2023-07-07 Daniel Fulford, Daphne J Holt
Background and Hypothesis Some of the most debilitating aspects of schizophrenia and other serious mental illnesses (SMI) are the impairments in social perception, motivation, and behavior that frequently accompany these conditions. These impairments may ultimately lead to chronic social disconnection (ie, social withdrawal, objective isolation, and perceived social isolation or loneliness), which
-
Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders Schizophr. Bull. (IF 6.6) Pub Date : 2023-07-07 Xiaoyan Li, Aotian Shen, Yiran Zhao, Junfeng Xia
Background and hypothesis Psychiatric disorders impose a huge health and economic burden on modern society. However, there is currently no proven completely effective treatment available, partly owing to the inefficiency of drug target identification and validation. We aim to identify therapeutic targets relevant to psychiatric disorders by conducting Mendelian randomization (MR) analysis. Study design
-
Approaches to Studying and Improving Social Motivation in Schizophrenia Schizophr. Bull. (IF 6.6) Pub Date : 2023-07-06 Lauren T Catalano, Michael F Green
Social motivation impairments, or “asociality,” have long been considered a core clinical feature of schizophrenia. Although the prevalence and pervasive negative impact of poor social motivation is well-documented, our understanding is limited regarding causal mechanisms. Advances in definition, conceptualization, and characterization are needed to inform research aimed at understanding these mechanisms
-
Transdiagnostic Predictors of Everyday Functioning: Examining the Relationships of Depression and Reinforcement Learning Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-29 Nada Dalloul, Erin K Moran, James M Gold, Cameron S Carter, Angus W MacDonald, J Daniel Ragland, Steven M Silverstein, Steven J Luck, Deanna M Barch
Background and Hypothesis Impairments in function (ie, the ability to independently accomplish daily tasks) have been established in psychotic disorders. Identifying factors that contribute to these deficits is essential to developing effective interventions. The current study had several goals: examine potential differential relationships across domains of neurocognition, assess whether reinforcement
-
Children at Familial High risk of Schizophrenia and Bipolar Disorder Exhibit Altered Connectivity Patterns During Pre-attentive Processing of an Auditory Prediction Error Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-28 Kit Melissa Larsen, Kathrine Skak Madsen, Anna Hester Ver Loren van Themaat, Anne Amalie Elgaard Thorup, Kerstin Jessica Plessen, Ole Mors, Merete Nordentoft, Hartwig Roman Siebner
Background and Hypothesis Individuals with schizophrenia or bipolar disorder have attenuated auditory mismatch negativity (MMN) responses, indicating impaired sensory information processing. Computational models of effective connectivity between brain areas underlying MMN responses show reduced connectivity between fronto-temporal areas in individuals with schizophrenia. Here we ask whether children
-
Review: Genes Involved in Mitochondrial Physiology Within 22q11.2 Deleted Region and Their Relevance to Schizophrenia Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-28 David Kolar, Branislav Krajcovic, Lenka Kleteckova, Daniela Kuncicka, Karel Vales, Hana Brozka
Background and Hypothesis Schizophrenia is associated with altered energy metabolism, but the cause and potential impact of these metabolic changes remain unknown. 22q11.2 deletion syndrome (22q11.2DS) represents a genetic risk factor for schizophrenia, which is associated with the loss of several genes involved in mitochondrial physiology. Here we examine how the haploinsufficiency of these genes
-
Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-26 Anya K Bershad, Harriet de Wit
Background and Hypothesis Diminished social motivation is a negative symptom of schizophrenia and leads to severe functional consequences for many patients suffering from the illness. However, there are no effective medications available to treat this symptom. Despite the lack of approved treatments for patients, there is a growing body of literature on the effects of several classes of drugs on social
-
Associations Between Childhood Area-Level Social Fragmentation, Maladaptation to School, and Social Functioning Among Healthy Youth and Those at Clinical High Risk for Psychosis Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-26 Benson S Ku, Jean Addington, Carrie E Bearden, Kristin S Cadenhead, Tyrone D Cannon, Michael T Compton, Barbara A Cornblatt, Benjamin G Druss, Sinan Gülöksüz, Daniel H Mathalon, Diana O Perkins, Ming T Tsuang, Elaine F Walker, Scott W Woods, Ricardo E Carrión
Background and Hypothesis Although studies have identified social fragmentation as an important risk factor for schizophrenia and other psychotic disorders, it is unknown whether it may impact social functioning. This study investigates whether social fragmentation during childhood predicts maladaptation to school as well as social functioning during childhood and adulthood. Study Design Data were
-
Altered Sex Differences in Hippocampal Subfield Volumes in Schizophrenia Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-25 Claudia Barth, Stener Nerland, Kjetil N Jørgensen, Beathe Haatveit, Laura A Wortinger, Ingrid Melle, Unn K Haukvik, Torill Ueland, Ole A Andreassen, Ingrid Agartz
Background and Hypothesis The hippocampus is a heterogenous brain structure that differs between the sexes and has been implicated in the pathophysiology of psychiatric illnesses. Here, we explored sex and diagnostic group differences in hippocampal subfield volumes, in individuals with schizophrenia spectrum disorder (SZ), bipolar disorders (BD), and healthy controls (CTL). Study Design One thousand
-
Linking Polygenic Risk of Schizophrenia to Variation in Magnetic Resonance Imaging Brain Measures: A Comprehensive Systematic Review Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-25 Hadis Jameei, Divyangana Rakesh, Andrew Zalesky, Murray J Cairns, William R Reay, Naomi R Wray, Maria A Di Biase
Background and hypothesis Schizophrenia is highly heritable, with a polygenic effect of many genes conferring risk. Evidence on whether cumulative risk also predicts alterations in brain morphology and function is inconsistent. This systematic review examined evidence for schizophrenia polygenic risk score (sczPRS) associations with commonly used magnetic resonance imaging (MRI) measures. We expected
-
Social Motivation in Schizophrenia: What’s Effort Got to Do With It? Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-25 Lauren T Catalano, Michael F Green
Background and Hypothesis Social motivation, defined as the fundamental human desire to seek out, engage in, and maintain interpersonal bonds, has become a growing area of research in schizophrenia. The major focus has been on understanding the impact of social reward-related processes. An obvious but rarely acknowledged fact is that social interactions, much like other goal-directed acts, require
-
Phenomenological and Cognitive Features Associated With Auditory Hallucinations in Clinical and Nonclinical Voice Hearers Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-24 James M Gold, Philip R Corlett, Molly Erickson, James A Waltz, Sharon August, Jenna Dutterer, Sonia Bansal
Background and Hypotheses Auditory verbal hallucinations (AVH) are central features of schizophrenia (SZ). However, AVH also occur in a small percentage of the general population who do not have a need for care, termed nonclinical voice hearers (NCVH). We sought to determine the degree to which the experience of AVH was similar in NCVH and in people with schizophrenia (PSZ) and evaluate the degree
-
Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-24 Dongfang Wang, Johannes Schneider-Thoma, Spyridon Siafis, Angelika Burschinski, Shimeng Dong, Hui Wu, Yikang Zhu, John M Davis, Josef Priller, Stefan Leucht
Background and Hypothesis Long-acting injectable antipsychotic drugs (LAIs) are mainly used for relapse prevention but could also be advantageous for acutely ill patients with schizophrenia. Study Design We conducted a systematic review and meta-analysis of randomized-controlled-trials (RCTs) comparing the second-generation long-acting injectable antipsychotics (SGA-LAIs) olanzapine, risperidone, paliperidone
-
Correction to: Heightened COVID-19 Mortality in People With Severe Mental Illness Persists After Vaccination: A Cohort Study of Greater Manchester Residents Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-20
Background and hypothesis Previous studies show that people with severe mental illness (SMI) are at higher risk of COVID-19 mortality, however limited evidence exists regarding risk post-vaccination. We investigated COVID-19 mortality among people with schizophrenia and other SMIs before, during and after the UK vaccine roll-out. Study Design Using the Greater Manchester (GM) Care Record to access
-
Shared Genetic Loci Between Schizophrenia and White Blood Cell Counts Suggest Genetically Determined Systemic Immune Abnormalities Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-16 Nils Eiel Steen, Zillur Rahman, Attila Szabo, Guy F L Hindley, Nadine Parker, Weiqiu Cheng, Aihua Lin, Kevin S O’Connell, Mashhood A Sheikh, Alexey Shadrin, Shahram Bahrami, Sandeep Karthikeyan, Eva Z Hoseth, Anders M Dale, Pål Aukrust, Olav B Smeland, Thor Ueland, Oleksandr Frei, Srdjan Djurovic, Ole A Andreassen
Background Immune mechanisms are indicated in schizophrenia (SCZ). Recent genome-wide association studies (GWAS) have identified genetic variants associated with SCZ and immune-related phenotypes. Here, we use cutting edge statistical tools to identify shared genetic variants between SCZ and white blood cell (WBC) counts and further understand the role of the immune system in SCZ. Study Design GWAS
-
Tracing the Roots of Dementia Praecox: Charles Lasègue and his 1852 Essay “Du Délire De Persécutions” (On Persecutory Delusions) Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-15 Kenneth S Kendler
While the evolution of our modern concepts of mania and melancholia over the 19th century is relatively well-understood, no such clear narrative exists for the nonaffective psychotic syndromes that culminated in Kraepelin’s concept of dementia praecox in 1899. These narratives were relatively distinct in Germany and France. An important milestone in the French literature is the 1852 essay by the alienist
-
Disparities in Psychosis Risk Symptoms for New Zealand Māori May Be Explained by Systemic Stressors and Inappropriate Conceptualization of Culturally Normative Experiences Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-15 Rebecca E Grattan, Aleesha Mehta, Amanda Clifford
Background and Hypothesis Māori, the indigenous peoples of New Zealand, experience increased rates of psychotic disorders and first-episode psychosis. However, it is unclear whether they also present with increased psychosis risk symptoms, such as subclinical psychotic-like experiences (PLEs). Measurement of risk symptoms is key for early intervention. Further, it is unclear if systemic factors such
-
Childhood Adversity and Emerging Psychotic Experiences: A Network Perspective Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-15 Zhiling Qiao, Ginette Lafit, Aleksandra Lecei, Robin Achterhof, Olivia J Kirtley, Anu P Hiekkaranta, Noëmi Hagemann, Karlijn S F M Hermans, Bart Boets, Ulrich Reininghaus, Inez Myin-Germeys, Ruud van Winkel
Background and Hypothesis Childhood adversity is associated with a myriad of psychiatric symptoms, including psychotic experiences (PEs), and with multiple psychological processes that may all mediate these associations. Study Design Using a network approach, the present study examined the complex interactions between childhood adversity, PEs, other psychiatric symptoms, and multiple psychological
-
Impaired Sleep Mediates the Relationship Between Interpersonal Trauma and Subtypes of Delusional Ideation Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-14 Emma N Herms, Amanda R Bolbecker, Krista M Wisner
Background and Hypothesis Trauma is a robust risk factor for delusional ideation. However, the specificity and processes underlying this relationship are unclear. Qualitatively, interpersonal traumas (i.e., trauma caused by another person) appear to have a specific relationship with delusional ideation, particularly paranoia, given the commonality of social threat. However, this has not been empirically
-
Familiality of the Intelligence Quotient in First Episode Psychosis: Is the Degree of Family Resemblance Associated With Different Profiles? Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-14 Nancy Murillo-García, Jordi Soler, Victor Ortiz-García de la Foz, Margarita Miguel-Corredera, Sara Barrio-Martinez, Esther Setién-Suero, Sergi Papiol, Mar Fatjó-Vilas, Rosa Ayesa-Arriola
Background and Hypothesis There is uncertainty about the relationship between the family intelligence quotient (IQ) deviation and the risk for schizophrenia spectrum disorders (SSD). This study tested the hypothesis that IQ is familial in first episode psychosis (FEP) patients and that their degree of familial resemblance is associated with different profiles. Study Design The participants of the PAFIP-FAMILIAS
-
Pleiotropic Association of CACNA1C Variants With Neuropsychiatric Disorders Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-12 Zuxing Wang, Xiandong Lin, Xinqun Luo, Jun Xiao, Yong Zhang, Jianying Xu, Shibin Wang, Fen Zhao, Huifen Wang, Hangxiao Zheng, Wei Zhang, Chen Lin, Zewen Tan, Liping Cao, Zhiren Wang, Yunlong Tan, Wenzhong Chen, Yuping Cao, Xiaoyun Guo, Christopher Pittenger, Xingguang Luo
Background Neuropsychiatric disorders are highly heritable and have overlapping genetic underpinnings. Single nucleotide polymorphisms (SNPs) in the gene CACNA1C have been associated with several neuropsychiatric disorders, across multiple genome-wide association studies. Method A total of 70,711 subjects from 37 independent cohorts with 13 different neuropsychiatric disorders were meta-analyzed to
-
Psychometric Properties and Diagnostic Associations of the Short-Form Community Assessment of Psychic Experiences in a Population-Based Sample of 29 021 Adult Men Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-02 Viktoria Birkenæs, Nora Refsum Bakken, Evgeniia Frei, Piotr Jaholkowski, Olav B Smeland, Markos Tesfaye, Ingrid Agartz, Ezra Susser, Michaeline Bresnahan, Espen Røysamb, Kjetil Nordbø Jørgensen, Ragnar Nesvåg, Alexandra Havdahl, Ole A Andreassen, Ida Elken Sønderby
Background and Hypothesis Around 5%–7% of the adult population are estimated to have lifetime psychotic experiences (PEs), which are associated with psychosis risk. PEs assessed with Community Assessment of Psychic Experiences (CAPE) are associated with psychosis but also non-psychotic disorders, which could be partly explained by CAPE indirectly capturing emotional symptoms. We investigated the psychometric
-
The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services: Results From the Horyzons Randomized Controlled Trial Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-01 Lidia Engel, Mario Alvarez-Jimenez, Daniela Cagliarini, Simon D’Alfonso, Jan Faller, Lee Valentine, Peter Koval, Sarah Bendall, Shaunagh O’Sullivan, Simon Rice, Chris Miles, David L Penn, Jess Phillips, Penni Russon, Reeva Lederman, Eoin Killackey, Shalini Lal, Sue Maree Cotton, Cesar Gonzalez-Blanch, Helen Herrman, Patrick D McGorry, John F M Gleeson, Cathrine Mihalopoulos
Background Digital interventions have potential applications in promoting long-term recovery and improving outcomes in first-episode psychosis (FEP). This study aimed to evaluate the cost-effectiveness of Horyzons, a novel online social therapy to support young people aged 16–27 years following discharge from FEP services, compared with treatment as usual (TAU) from a healthcare sector and a societal
-
A Systematic Review and Meta-Analysis of the Association Between Psychopathology and Social Functioning in Schizophrenia Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-01 Rasmus Handest, Ida-Marie Molstrom, Mads Gram Henriksen, Carsten Hjorthøj, Julie Nordgaard
Background Impaired social functioning is a major, but under-elucidated area of schizophrenia. It’s typically understood as consequential to, eg, negative symptoms, but meta-analyses on the subject have not examined psychopathology in a broader perspective and there’s severe heterogeneity in outcome measures. To enhance functional recovery from schizophrenia, a more comprehensive understanding of the
-
Longitudinal Investigation of Auditory Dynamic Range Deficits in Early Psychosis and its Relationship to Negative Symptoms Schizophr. Bull. (IF 6.6) Pub Date : 2023-06-01 Alfredo L Sklar, Sayna Matinrazm, Xi Ren, Lydia Chlpka, Mark Curtis, Brian A Coffman, Dean F Salisbury
Background and Hypothesis Despite accounting for significant disease morbidity in schizophrenia, the neuropathological basis of negative symptoms remains poorly understood and options for treatment limited. Our recent study identified robust associations between diminished auditory cortex (AC) dynamic range and social functioning impairments and negative symptoms in first episode psychosis (FESz).